Rostrum & Thornhill research announce technology development agreement.

Toronto, ON and Vancouver, BC Canada – November 29, 2017 – Thornhill and Rostrum celebrate the finalization of a Technology Development Agreement which includes the licensing of certain Thornhill IP and an investment by Rostrum into Thornhill. This agreement is aimed to further Rostrum’s development of its Pulmonary Health Monitoring during ventilation, in ICU, OR and ER applications, while supporting Thornhill’s commercialization efforts of their own innovative products.

November-2017-Press-Release-Thornhill-Agreement